Workers remain optimistic about negotiations with Town of Placentia
ST. JOHN'S, Aug. 28, 2018 /CNW/ - Representatives for the Canadian Union of Public Employees (CUPE) Local 1761 remain hopeful that a negotiated collective agreement can be reached with the Town of Placentia, despite receiving notice yesterday that the employer has applied for conciliation.
Six exchanges have taken place since bargaining began in May 2018.
"We're disappointed that the Town has taken this step, which we feel is premature at this time," says Derrick Barrett, CUPE national representative. "Progress has been made and issues have been resolved through the regular collective bargaining process."
CUPE 1761 President Gerry Quilty says, "Negotiations are going well from our perspective. We believe that we're on our way to reaching a fair deal."
"We remain hopeful that we can reach a negotiated deal that is good for the workers and the Town of Placentia," adds Barrett.
CUPE 1761 represents 15 members who are inside and outside municipal workers with the Town of Placentia.
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024
First Quarter 2024
Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...
Galantas Gold Corporation (the ?Company') is pleased to announce its audited annual financial results for the year ended December 31, 2023. A copy of the Financial Statements and Management Discussion and Analysis will be sent to shareholders in due...
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
The earnings release can be found at...
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. .
Juniper Re will...
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...
